Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies.

Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies.

Item
http://www.wikidata.org/entity/Q35530473
Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach.The Expression of Fibroblast Activation Protein in Clear Cell Renal Cell Carcinomas Is Associated with Synchronous Lymph Node Metastases.Prognostic significance of platelet-lymphocyte ratio in patients receiving first-line tyrosine kinase inhibitors for metastatic renal cell cancer.Clinical correlates and prognostic value of different metastatic sites in metastatic renal cell carcinoma.Current Management Options in Metastatic Renal Cell Cancer.The rationale and the role of lymph node dissection in renal cell carcinoma.Comprehensive analysis and validation of contemporary survival prognosticators in Korean patients with metastatic renal cell carcinoma treated with targeted therapy: prognostic impact of pretreatment neutrophil-to-lymphocyte ratio.Oncological outcomes classified according to metastatic lesions in the era of molecular targeted drugs for metastatic renal cancer.
P2860

Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies.

Item
http://www.wikidata.org/entity/Q35530473
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Characterizing the impact of l ...... eated with targeted therapies.
@ast
Characterizing the impact of l ...... eated with targeted therapies.
@en
type
label
Characterizing the impact of l ...... eated with targeted therapies.
@ast
Characterizing the impact of l ...... eated with targeted therapies.
@en
prefLabel
Characterizing the impact of l ...... eated with targeted therapies.
@ast
Characterizing the impact of l ...... eated with targeted therapies.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Characterizing the impact of l ...... reated with targeted therapies
@en
P2093
P304
P31
P356
10.1016/J.EURURO.2014.11.054
P407
P433
P478
P50
P577
P5875
P698